AIP
FBLG icon

Ameritas Investment Partners’s FibroBiologics FBLG Stock Holding History

Ameritas Investment Partners’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-125
Closed -$2.24K – 3365
2025
Q1 		$2.24K Hold
125
– – ﹤0.01% 3068
2024
Q4 		$4.99K Hold
125
– – ﹤0.01% 3024
2024
Q3 		$7.7K Hold
125
– – ﹤0.01% 2983
2024
Q2 		$12.4K Buy
+125
New +$23.8K ﹤0.01% 2843

Other funds holding FBLG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Investment Partners's FBLG Position: Q2 2025 in Review

Ameritas Investment Partners sold out of FibroBiologics (FBLG) in Q2 2025, closing a stake of 125 shares — an estimated $2.24K sold.

Ameritas Investment Partners first reported a position in FBLG in Q2 2024 and held it in 4 quarters. The position peaked at $12.4K in Q2 2024. 57 funds tracked by Wall St. Rank hold FBLG as of Q2 2025.

  • Ameritas Investment Partners reported no remaining FibroBiologics position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 125 FibroBiologics shares in Q2 2025, an estimated $2.24K.
  • Ameritas Investment Partners first reported a position in FibroBiologics in Q2 2024 and held it in 4 quarters.
  • Ameritas Investment Partners's FibroBiologics position peaked at $12.4K in Q2 2024.
  • 57 funds tracked by Wall St. Rank held FibroBiologics as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.